OTHER INFORMATION.
−Removed: During the fiscal quarter ended March 31, 2026, none of our officers or directors, as those terms are defined in Rule 16a-1(f), adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Item 408 of Regulation S-K.
−Removed: Nasdaq Deficiency
−Removed: On May 13, 2026, we received the Notice from the
−Removed: Listing Qualifications Department of Nasdaq notifying us that we were not currently in compliance with Nasdaq Listing Rule 5450(b)(2)(A),
−Removed: which requires listed securities to maintain an MVLS of $50 million.
−Removed: According to the Notice, our MVLS had been below
−Removed: $50 million for 30 consecutive business days from March 27, 2026 through May 12, 2026.
−Removed: In accordance with Nasdaq Listing Rule 5810(c)(3)(C),
−Removed: we have been provided with a compliance period of 180 calendar days, or until November 9, 2026, to regain compliance with the minimum
−Removed: MVLS requirement.
−Removed: The Notice has no immediate effect on the listing
−Removed: or trading of our common stock on the Nasdaq Global Market.
−Removed: If at any time during the compliance period our MVLS closes at $50 million
−Removed: or more for a minimum of 10 consecutive business days, Nasdaq will provide written confirmation that we have regained compliance with
−Removed: the applicable requirement, and the matter will be closed.
−Removed: If we do not regain compliance
−Removed: with the Nasdaq Global Market continued listing requirements by November 9, 2026, and if we otherwise satisfy the applicable listing requirements
−Removed: for the Nasdaq Capital Market, Nasdaq may permit our securities to remain listed on Nasdaq through a transfer of the listing of our securities
−Removed: from the Nasdaq Global Market to the Nasdaq Capital Market.
−Removed: However, there can be no assurance that we will regain compliance with the
−Removed: Nasdaq Global Market requirements or qualify for continued listing on the Nasdaq Capital Market.
+Added: During the fiscal quarter ended June 30, 2026, none of our officers or directors, as those terms are defined in Rule 16a-1(f), adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Item 408 of Regulation S-K.
+Added: Executive Compensation
+Added: On August 11, 2026, the Compensation Committee of our board of directors approved certain changes to the compensation of the Company’s Chief Revenue Officer and Chief Financial Officer.
+Added: Effective October 1, 2026, the annual base salary of Emmanuel Heymann, the Company’s Chief Revenue Officer, will increase from $276,000 to $310,000.
+Added: In addition, effective January 1, 2027, Mr.
+Added: Heymann’s sales commission will increase from 2.0% to 2.5% of revenues, as defined in his commission plan.
+Added: Effective October 1, 2026, the monthly base salary of Yael Sandler, the Company’s Chief Financial Officer, will increase from NIS 70,000 to NIS 80,000.
+Added: In addition, effective October 1, 2026, the Company’s contributions to Ms.
+Added: Sandler’s education fund (Keren Hishtalmut) will be calculated based on her entire monthly base salary, at a rate of 7.5%, rather than being limited to the applicable tax-exempt ceiling.
+Added: Exhibit Description Schedule/
+Added: Number Exhibit File Date
2.1 Merger Agreement, as amended.
−Removed: January 13, 2026
+Added: S-4/A 333-283153 2.1 January 13, 2026
3.1 Certificate of Incorporation of Cyabra, Inc.
−Removed: March 31, 2026
+Added: 8-K 001-43214 3.1 March 31, 2026
3.2 Bylaws of Cyabra, Inc.
−Removed: January 13, 2026
+Added: S-4/A 333-283153 3.7 January 13, 2026
+Added: 3.3 Amendment No.
+Added: 1 to the Amended and Restated Bylaws of Cyabra, Inc.
+Added: 8-K 001-43214 3.1 July 31, 2026
3.4 Certificate of Designation of Holdings relating to the Series A Convertible Preferred Stock.
−Removed: March 31, 2026
+Added: 8-K 001-43214 3.3 March 31, 2026
3.5 Certificate of Designation of Holdings relating to the Series B Convertible Preferred Stock.
−Removed: March 31, 2026
+Added: 8-K 001-43214 3.4 March 31, 2026
3.6 Certificate of Designation of Holdings relating to the Series C Convertible Preferred Stock.
−Removed: March 31, 2026
+Added: 8-K 001-43214 3.5 March 31, 2026
10.1 Form of Lock-up Agreement .
−Removed: July 23, 2024
+Added: 8-K 001-41668 10.3 July 23, 2024
+Added: 10.2† Cyabra, Inc.
2026 Omnibus Equity Incentive Plan.
−Removed: March 31, 2026
+Added: 8-K 001-43214 10.4 March 31, 2026
10.3† Form of Incentive Stock Option Grant Agreement under the Cyabra, Inc.
2026 Omnibus Equity Incentive Plan.
−Removed: December 20, 2024
+Added: S-4/A 333-283153 10.23 December 20, 2024
10.4† Form of Non-Qualified Stock Option Grant Agreement under the Cyabra, Inc.
2026 Omnibus Equity Incentive Plan.
−Removed: December 20, 2024
+Added: S-4/A 333-283153 10.24 December 20, 2024
10.5† Form of Section 102 Restricted Stock Unit Agreement under the Cyabra, Inc.
2026 Omnibus Equity Incentive Plan.
−Removed: March 31, 2026
+Added: 8-K 001-43214 10.7 March 31, 2026
10.6† Form of Restricted Stock Unit Agreement under the Cyabra, Inc.
2026 Omnibus Equity Incentive Plan.
−Removed: December 20, 2024
+Added: S-4/A 333-283153 10.25 December 20, 2024
10.7† Form of Restricted Stock Award Agreement under the Cyabra, Inc.
2026 Omnibus Equity Incentive Plan.
−Removed: December 20, 2024
+Added: S-4/A 333-283153 10.26 December 20, 2024
10.8† Form of Section 3(i) Option Grant Agreement under the Cyabra, Inc.
2026 Omnibus Equity Incentive Plan and 2026 Israeli Sub-Plan.
−Removed: December 20, 2024
+Added: S-4/A 333-283153 10.27 December 20, 2024
10.9† Form of Section 102 Option Grant Agreement under the Cyabra, Inc.
2026 Omnibus Equity Incentive Plan and 2026 Israeli Sub-Plan.
−Removed: December 20, 2024
+Added: S-4/A 333-283153 10.28 December 20, 2024
10.10 Facility Agreement, dated May 30, 2022, between Cyabra and Bank Hapoalim B.M.
−Removed: January 13, 2026
+Added: S-4/A 333-283153 10.31 January 13, 2026
10.11 Offer of Employment, dated December 29, 2022 by and between Cyabra Strategy Inc.
and Emmanuel Heymann.
−Removed: January 13, 2026
+Added: S-4/A 333-283153 10.36 January 13, 2026
10.12 Employment Agreement dated June 18, 2024 by and between Cyabra Strategy Ltd.
and Yael Sandler.
−Removed: January 13, 2026
+Added: S-4/A 333-283153 10.37 January 13, 2026
10.13 Amendment to Offer of Employment, by and between Cyabra Strategy Inc.
and Emmanuel Heymann, dated August 15, 2024.
−Removed: January 13, 2026
+Added: S-4/A 333-283153 10.38 January 13, 2026
10.14 Form of Indemnification Agreement.
−Removed: January 13, 2026
+Added: S-4/A 333-283153 10.39 January 13, 2026
10.15 Registration Rights Agreement, dated March 27, 2026, between Trailblazer Holdings, Inc.
and certain investors.
−Removed: March 31, 2026
+Added: 8-K 001-43214 10.19 March 31, 2026
10.16 Offer of Employment, dated February 10, 2025 by and between Cyabra Strategy Inc.
and Dan Brahmy.
−Removed: January 13, 2026
+Added: S-4/A 333-283153 10.40 January 13, 2026
10.17 Amendment to Employment Agreement dated February 10, 2025 by and between Yossef Daar and Cyabra Strategy Ltd.
−Removed: January 13, 2026
+Added: S-4/A 333-283153 10.41 January 13, 2026
10.18 Amendment to Employment Agreement dated February 10, 2025 by and between Ido Shraga and Cyabra Strategy Ltd.
−Removed: January 13, 2026
+Added: S-4/A 333-283153 10.42 January 13, 2026
10.19 Securities Purchase Agreement dated December 18, 2025, between Trailblazer Holdings, Inc.
and certain purchasers.
−Removed: January 13, 2026
−Removed: Registration Rights Agreement dated December 18, 2025, between Trailblazer Holdings, Inc.
−Removed: and certain purchasers.
−Removed: January 13, 2026
+Added: S-4/A 333-283153 10.45 January 13, 2026
+Added: Exhibit Description Schedule/
+Added: Number Exhibit File Date
10.20 Form of Common Stock Purchase Warrant.
−Removed: March 31, 2026
+Added: 8-K 001-43214 10.25 March 31, 2026
10.21 Deferred Fee Agreement, dated October 28, 2025.
−Removed: November 3, 2025
+Added: 8-K 001-41668 10.1 November 3, 2025
10.22 Amendment to Advisory Agreement, dated October 28, 2025.
−Removed: November 3, 2025
+Added: 8-K 001-41668 10.2 November 3, 2025
10.23 LifeSci Advisory Agreement, dated October 28, 2025.
−Removed: November 3, 2025
+Added: 8-K 001-41668 10.3 November 3, 2025
10.24 Ladenburg Advisory Agreement dated October 28, 2025.
−Removed: November 3, 2025
+Added: 8-K 001-41668 10.4 November 3, 2025
10.25 Note Issuance Agreement among Cyabra, Trailblazer Merger Corporation I, Trailblazer Holdings, Inc.
and Lowenstein Sandler LLP.
−Removed: January 13, 2026
+Added: S-4/A 333-283153 10.52 January 13, 2026
10.26 Note Issuance Agreement among Cyabra, Trailblazer Merger Corporation I, Trailblazer Holdings, Inc.
and Loeb & Loeb LLP.
−Removed: January 13, 2026
+Added: S-4/A 333-283153 10.53 January 13, 2026
10.27 Promissory Note, dated February 4, 2026.
−Removed: March 31, 2026
+Added: 8-K 001-43214 10.32 March 31, 2026
10.28 Promissory Note, dated March 9, 2026.
−Removed: March 31, 2026
+Added: 8-K 001-43214 10.33 March 31, 2026
10.29 Amendment to Employment Agreement, dated March 16, 2026, between Cyabra, Inc.
and Yossef Daar.
−Removed: March 31, 2026
+Added: 8-K 001-43214 10.34 March 31, 2026
10.30 Amendment to Employment Agreement, dated March 16, 2026, between Cyabra, Inc.
and Ido Shraga.
−Removed: March 31, 2026
+Added: 8-K 001-43214 10.35 March 31, 2026
10.31 Lock-up Agreement, dated March 27, 2026.
−Removed: March 31, 2026
+Added: 8-K 001-43214 10.36 March 31, 2026
+Added: 10.32 Letter Agreements, dated March 28, 2023, by and among Trailblazer and each of the Company’s officers, directors and initial stockholders.
+Added: 8-K 001-41668 10.1 April 3, 2023
+Added: 10.33 Investment Management Trust Agreement, dated March 28, 2023, by and between Trailblazer and Continental Stock Transfer & Trust Company, LLC.
+Added: 8-K 001-41668 10.2 April 3, 2023
+Added: 10.34 Registration Rights Agreement, dated March 28, 2023, by and among Trailblazer and certain security holders.
+Added: 8-K 001-41668 10.3 April 3, 2023
+Added: 10.35 Indemnity Agreements, each dated as of March 28, 2023, by and between Trailblazer and each of the officers and directors of the Registrant.
+Added: 8-K 001-41668 10.4 April 3, 2023
+Added: 10.36 Stock Escrow Agreement, dated March 28, 2023, by and among Trailblazer, Continental Stock Transfer & Trust Company and the initial stockholders of the Company.
+Added: 8-K 001-41668 10.5 April 3, 2023
+Added: 10.37 Private Placement Units Purchase Agreement, dated March 28, 2023, by and among Trailblazer and the initial stockholders of Trailblazer party thereto.
+Added: 8-K 001-41668 10.6 April 3, 2023
+Added: 10.38 Promissory Note, dated May 17, 2022.
+Added: S-1/A 333-265914 10.2 January 31, 2023
+Added: 10.39 Amendment to Promissory Note, dated January 20, 2023.
+Added: S-1/A 333-265914 10.3 January 31, 2023
+Added: 10.40 Amendment to Promissory Note, dated March 31, 2023.
+Added: 8-K 001-41668 2.1 April 28, 2023
+Added: 10.41 Amendment to Promissory Note, dated March 27, 2024.
+Added: 10-K 001-41668 10.14 March 29, 2024
+Added: 10.42 Amendment to Promissory Note, dated September 16, 2024.
+Added: 8-K 001-41668 2.1 September 20, 2024
+Added: 10.43 Amendment to Promissory Note, dated September 30, 2024.
+Added: 8-K 001-41668 10.1 September 30, 2024
+Added: 10.44 Subscription Agreement for Sponsor Shares, dated May 17, 2022.
+Added: S-1/A 333-265914 10.6 January 31, 2023
+Added: 10.45 Share Exchange Agreement dated September 23, 2022.
+Added: S-1/A 333-265914 10.10 January 31, 2023
+Added: 10.46 Sponsor Shares Forfeiture Agreement, dated January 20, 2023.
+Added: S-1/A 333-265914 10.11 January 31, 2023
+Added: 10.47 Advisory Agreement, dated September 23, 2022, between the Trailblazer Sponsor Group, LLC and LifeSci Capital LLC.
+Added: S-1/A 333-265914 10.12 March 13, 2023
+Added: 10.48 Amendment No.
+Added: 1 to the Advisory Agreement, dated March 9, 2023, between the Trailblazer Sponsor Group, LLC and LifeSci Capital LLC.
+Added: S-1/A 333-265914 10.13 March 13, 2023
+Added: 10.49 Parent Support Agreement, dated July 22, 2024.
+Added: 8-K 001-41668 10.1 July 23, 2024
+Added: 10.50 Company Support Agreement, dated July 22, 2024.
+Added: 8-K 001-41668 10.2 July 23, 2024
+Added: 10.51 Form of Lock-up Agreement.
+Added: 8-K 001-41668 10.3 July 23, 2024
+Added: 10.52 Waiver and Consent Letter of Alpha Capital Anstalt dated March 19, 2026 and Side Letter with respect to Beneficial Ownership dated March 19, 2026.
+Added: S-1/A 333-293035 10.54 March 23, 2026
+Added: 10.53 Form of Securities Purchase Agreement 8-K 001-43214 10.1 July 10, 2026
+Added: 10.54 Placement Agent Agreement, dated July 9, 2026, by and between Cyabra, Inc.
+Added: and A.G.P./Alliance Global Partners 8-K 001-43214 10.2 July 10, 2026
+Added: 10.55 Form of Conversion Agreement 8-K 001-43214 10.3 July 10, 2026
+Added: 10.56 Exchange Agreement, dated July 9, 2026, by and between Cyabra, Inc.
+Added: and Alpha Capital Anstalt 8-K 001-43214 10.4 July 10, 2026
31.1* Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a)
1 unchanged sentence
32.1* Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C.
−Removed: Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
−Removed: Inline XBRL Taxonomy Extension Schema Document
−Removed: Inline XBRL Taxonomy Extension Calculation Linkbase Document
−Removed: Inline XBRL Taxonomy Extension Definition Linkbase Document
−Removed: Inline XBRL Taxonomy Extension Label Linkbase Document
−Removed: Inline XBRL Taxonomy Extension Presentation Linkbase Document
+Added: 101.INS* Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
+Added: 101.SCH* Inline XBRL Taxonomy Extension Schema Document
+Added: 101.CAL* Inline XBRL Taxonomy Extension Calculation Linkbase Document
+Added: 101.DEF* Inline XBRL Taxonomy Extension Definition Linkbase Document
+Added: 101.LAB* Inline XBRL Taxonomy Extension Label Linkbase Document
+Added: 101.PRE* Inline XBRL Taxonomy Extension Presentation Linkbase Document
104* Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
3 unchanged sentences
The Registrant agrees to furnish supplementally a copy of any omitted schedule or exhibit to the SEC upon request.
−Removed: Pursuant to the requirements of the Securities Exchange Act of 1934,
−Removed: the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
+Added: Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
+Added: August 13, 2026 By:
/s/ Dan Brahmy
1 unchanged sentence
(Principal Executive Officer)
+Added: August 13, 2026 By:
/s/ Yael Sandler
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.